PMID- 35076020 OWN - NLM STAT- MEDLINE DCOM- 20220725 LR - 20230723 IS - 1969-6213 (Electronic) IS - 1774-024X (Print) IS - 1774-024X (Linking) VI - 18 IP - 4 DP - 2022 Jul 22 TI - Trends and predictors of radiation exposure in percutaneous coronary intervention: the PROTECTION VIII study. PG - e324-e332 LID - EIJ-D-21-00856 [pii] LID - 10.4244/EIJ-D-21-00856 [doi] AB - BACKGROUND: Percutaneous coronary intervention (PCI) is indispensable in cardiology; however, exposure to potentially harmful ionising radiation remains a concern. AIMS: This study was designed to assess the PCI-related radiation dose over the last decade and to identify predictors of increased dose exposure. METHODS: The PROcedural radiaTion dose Exposure in percutaneous Coronary intervenTION (PROTECTION VIII) study included all PCIs reported to a German quality assurance programme between 2008 and 2018. Dose area product (DAP) and radiation time were analysed. Effective dose (ED) was estimated (ED=DAP*k; conversion coefficient k=0.0022 mSv/cGy*cm(2)). Multivariate linear regression analysis was used to identify predictors associated with a clinically relevant increase of radiation dose (ED >/=1 mSv). RESULTS: We enrolled 3,704,986 patients undergoing PCI (median age 70 years, 30% female). Indications were chronic coronary syndrome (37.5%), unstable angina pectoris and non-ST-segment elevation myocardial infarction (non-STEMI; 33.2%) and STEMI (18.5%). Median DAP was 4,203 (interquartile range [IQR] 2,313-7,300) cGy*cm, ED was 9.2 mSv and median radiation time was 9.2 (IQR 5.8-15.0) min. Within the 10-year period, radiation exposure was reduced by 36% (p<0.001) and resulted in a median DAP of 3,070 cGy*cm (ED 6.8 mSv) in 2018. A significant 5.3-fold variability of median DAP was observed between catheterisation laboratories (p<0.001). We identified patient-related (gender, coronary artery bypass graft surgery, heart failure) and procedure-related (coronary occlusion PCI, ostial lesion PCI, left main PCI, multivessel PCI) predictors of increased radiation dose (all p<0.001). CONCLUSIONS: This radiation dose survey demonstrates a considerable reduction of PCI radiation exposure during the last decade. However, large variability between catheterisation laboratories underlines the need for further radiation dose reduction. FAU - Stocker, Thomas J AU - Stocker TJ AD - Medizinische Klinik und Poliklinik I, Klinikum der Universitat Munchen, Ludwig-Maximilians-Universitat, Munich, Germany. AD - DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. AD - European Alliance for Medical Radiation Protection Research (EURAMED): The EURAMED rocc-n-roll project (www.euramed.eu). FAU - Abdel-Wahab, Mohamed AU - Abdel-Wahab M AD - Heart Center Leipzig at University of Leipzig, Leipzig, Germany. FAU - Mollmann, Helge AU - Mollmann H AD - Department of Internal Medicine, Medizinische Klinik 1, St. Johannes-Hospital, Dortmund, Germany. FAU - Deseive, Simon AU - Deseive S AD - Medizinische Klinik und Poliklinik I, Klinikum der Universitat Munchen, Ludwig-Maximilians-Universitat, Munich, Germany. AD - DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. FAU - Massberg, Steffen AU - Massberg S AD - Medizinische Klinik und Poliklinik I, Klinikum der Universitat Munchen, Ludwig-Maximilians-Universitat, Munich, Germany. AD - DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. FAU - Hausleiter, Jorg AU - Hausleiter J AD - Medizinische Klinik und Poliklinik I, Klinikum der Universitat Munchen, Ludwig-Maximilians-Universitat, Munich, Germany. AD - DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany. AD - European Alliance for Medical Radiation Protection Research (EURAMED): The EURAMED rocc-n-roll project (www.euramed.eu). LA - eng PT - Journal Article DEP - 20220722 PL - France TA - EuroIntervention JT - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology JID - 101251040 SB - IM MH - Aged MH - Coronary Angiography/methods MH - *Coronary Occlusion/surgery MH - Female MH - Humans MH - Male MH - *Non-ST Elevated Myocardial Infarction MH - *Percutaneous Coronary Intervention/methods MH - Radiation Dosage MH - *Radiation Exposure/adverse effects MH - Risk Factors MH - *ST Elevation Myocardial Infarction/etiology MH - Treatment Outcome PMC - PMC9912963 COIS- J. Hausleiter has received speaker honoraria and research support from and serves as consultant for Abbott Vascular and Edwards Lifesciences. H. Mollmann has received speaker/proctor honoraria from Abbott Vascular, Boston Scientific, Edwards Lifesciences, Siemens Healthcare and SMT. The other authors have no conflicts of interest to declare. EDAT- 2022/01/26 06:00 MHDA- 2022/07/26 06:00 PMCR- 2023/07/22 CRDT- 2022/01/25 08:55 PHST- 2022/01/26 06:00 [pubmed] PHST- 2022/07/26 06:00 [medline] PHST- 2022/01/25 08:55 [entrez] PHST- 2023/07/22 00:00 [pmc-release] AID - EIJ-D-21-00856 [pii] AID - 10.4244/EIJ-D-21-00856 [doi] PST - epublish SO - EuroIntervention. 2022 Jul 22;18(4):e324-e332. doi: 10.4244/EIJ-D-21-00856.